Newsletter 2022 Archives - Regenerative Medicine at the McGowan Institute

Newsletter | June 2022

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2022 | June 30, 2022

June 2022 | VOL. 21, NO. 6| www.McGowan.pitt.edu

Dr. Stephen Badylak Named Inaugural Winner of the Jensen Tissue Engineering Award

McGowan Institute for Regenerative Medicine Deputy Director Stephen Badylak, DVM, PhD, MD, is the inaugural winner of the Jensen Tissue Engineering Award. This award—a gift from Ole Jensen, DDS, MS, a world-renowned oral surgeon and innovative businessman—was established “to recognize an individual (anywhere in the world) for sustained scientific contributions, translational impact towards clinical realization, and professional distinction in the field of tissue engineering and regenerative medicine.” Dr. Badylak will receive his award during the upcoming TERMIS-AM Meeting in Toronto between July 10-13, 2022. Read More

Newsletter | May 2022

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2022 | May 27, 2022

The study demonstrated significant improvement in strength and range of motion, as well as evidence for skeletal muscle regeneration

May 2022 | VOL. 21, NO. 5| www.McGowan.pitt.edu

Recruiting Patients – Clinical Trial – Volumetric Muscle Loss

We previously reported the results of a study conducted by researchers at the University of Pittsburgh School of Medicine and the McGowan Institute for Regenerative Medicine that showed significant improvement in strength and range of motion, as well as evidence for skeletal muscle regeneration, in 13 patients who were surgically implanted with bioscaffolds derived from pig tissue to treat muscle injuries. The patients had failed to respond to conventional treatment before use of the extracellular matrix (ECM). The findings were published online in npj Regenerative Medicine. Read More

Newsletter | April 2022

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2022 | April 27, 2022

Drs. Kacey Marra (top) and Eric Lagasse

April 2022 | VOL. 21, NO. 4| www.McGowan.pitt.edu

Drs. Kacey Marra and Eric Lagasse Recognized During Pitt’s Celebration of Innovation

The University of Pittsburgh Office of Innovation and Entrepreneurship presented its 2022 Celebration of Innovation on April 21, 2022. This event recognized the achievements of Pitt faculty and student innovators who are seeking to improve people’s lives through the commercialization of their ideas and discoveries. In addition to recognizing all faculty and students who submitted an invention disclosure, were issued a U.S. patent, or had their innovation licensed, there were seven special awards presented. The efforts of two McGowan Institute for Regenerative Medicine faculty members were recognized among these special awards. Read More

Newsletter | March 2022

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2022 | March 31, 2022

March 2022 | VOL. 21, NO. 3| www.McGowan.pitt.edu

Dr. David Kaczorowski on Xenotransplantation

McGowan Institute for Regenerative Medicine affiliated faculty member David Kaczorowski, MD, Surgical Director of the Advanced Heart Failure Center of UPMC Heart and Vascular Institute and an Associate Professor of Cardiothoracic Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, was a member of the surgical team on the historic first successful transplant of a porcine heart into an adult human with end-stage heart disease. As a follow-up to this extraordinary accomplishment by the surgical team, Dr. Kaczorowski published an article entitled, “Organs from genetically engineered pigs may help shorten the transplant wait list,” in The Conversation. The article focuses on the history of xenotransplantion, or transplanting animal organs into human beings. The article is repeated here: Read More

Newsletter | February 2022

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2022 | February 28, 2022

February 2022 | VOL. 21, NO. 2| www.McGowan.pitt.edu

New Peer-Reviewed Publication Expanding Liver Regeneration Technology

McGowan Institute for Regenerative Medicine faculty member Eric Lagasse, PharmD, PhD, is an Associate Professor in the Department of Pathology at the University of Pittsburgh and a co-founder and Chief Scientific Officer of LyGenesis, a clinical-stage biotechnology company developing cell therapies for patients with end stage liver disease, Type 1 diabetes, end stage renal disease, single enzyme deficiencies, and aging. Read More

Newsletter | January 2022

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2022 | January 28, 2022

January 2022 | VOL. 21, NO. 1| www.McGowan.pitt.edu

Dr. David Kaczorowski Member of Surgical Team on Historic First Successful Transplant of Porcine Heart into Adult Human with End-Stage Heart Disease

In a first-of-its-kind surgery, a 57-year-old patient with terminal heart disease received a successful transplant of a genetically modified pig heart and is still doing well three days later. It was the only currently available option for the patient. The historic surgery was conducted by University of Maryland School of Medicine (UMSOM) faculty at the University of Maryland Medical Center (UMMC), together known as the University of Maryland Medicine. Bartley P. Griffith, MD (pictured middle), surgically transplanted the pig heart into the patient. Read More